This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Jazz Pharmaceuticals Research UK Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Michael Simon Loft: Innovator in Cannabinoid Manufacturing
Introduction
Michael Simon Loft is a notable inventor based in Cambridgeshire, GB. He has made significant contributions to the pharmaceutical industry, particularly in the area of cannabinoid manufacturing. His innovative approach aims to enhance the stability and purity of cannabinoids used in pharmaceuticals, ultimately improving patient compliance.
Latest Patents
Michael Simon Loft holds a patent for a "Method of preparing cannabinoids." This invention addresses the challenges faced by the pharmaceutical industry regarding drug discolouration, which is a leading cause of drug recalls. The primary objective of his patent is to provide an improved method for manufacturing cannabinoids that are both stable and substantially pure. The main steps involved in this method include decarboxylation, extraction, winterization, and crystallization. This advancement is crucial for ensuring the safety and efficacy of cannabinoid-based medications.
Career Highlights
Michael Simon Loft is associated with Jazz Pharmaceuticals Research UK Limited, where he applies his expertise in cannabinoid research and development. His work is pivotal in advancing the pharmaceutical applications of cannabinoids, contributing to the overall improvement of medication quality.
Collaborations
Michael has collaborated with esteemed colleagues such as Alan Silcock and Alejandro Montellano Lopez. These partnerships have fostered a collaborative environment that enhances innovation and research in cannabinoid manufacturing.
Conclusion
Michael Simon Loft's contributions to cannabinoid manufacturing represent a significant advancement in the pharmaceutical industry. His patented method not only addresses critical issues related to drug stability and purity but also aims to improve patient compliance with medications. His work continues to influence the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile